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Ischemia-reperfusion (I-R) induces mitochondrial function impairments
and oxidative stress in skeletal muscle. In cardiac muscle, one-to-several days
of exercise attenuate I-R injury. The objective of the present study was to
show that a single exercise (EXO) prior to the I-R period protects the hind
limb mitochondrial function. Twenty mice were randomly divided into 2
groups: The control group (CTL I-R, n=10) underwent I-R without exercise
and the exercise group (EXO I-R, n=10) ran before I-R. Mice underwent 2
hours of ischemia induced by a rubber band tourniquet applied on the right
root of the hind limb (the left leg was used as control leg), followed by a
reperfusion period of 2 h. The EXO was performed on a treadmill with 10%
incline 1h before I-R. The mice ran at a speed of 30cm until 40cm/sec during
30min. Blood lactate obtained from the tip of the tail at the end of EXO was
above 9 mmol/L. In skinned gastrocnemius fibers, I-R significantly decreased
the maximal mitochondrial respiration (Vmax) of the ischemic leg in compar-
ison to the control leg in the CTL group (23.6 vs 28.6 pmol/(sec*mg wet
weight); p<0.05). EXO I-R mice increased Vmax in comparison to CTL I-R
mice (39.5 vs 31.8 pmol/(sec*dw) in the ischemic leg and the control leg
respectively; p<0.05)). After EXO, the impairment between ischemic leg and
control leg was partially restored (p=0.22). Without preconditioning, I-R
increased H202 production of the ischemic leg in comparison to the control
leg (42.6 vs 37.8  umol/mg dw; p=0.23). EXO I-R mice significantly
decreased the H202 production in comparison to CTL I-R mice (26.6 vs
42.6 umol/mg dw; p<0.01) in the ischemic leg. After EXO, the impairment
between ischemic leg and control leg was completely abolished (p=0.8). These
results show that a preconditioning exercise protect the maximal mitochon-
drial respiration in mice and reduce the mitochondrial production of ROS fol-
lowing a period of I-R.
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Stabilization of the Hypoxia Inducible Factor (HIF) using prolyl-hydroxy-
lase inhibitors (PHI) leads to an EPO synthesis which is suspected to be used
as a doping practice. Such a treatment is suspected to improve endurance per-
formance by increasing oxygen transport. However the effects of a PHI treat-
ment on heart morphology and function has never been investigated.
Therefore the aim of this study was to evaluate whether potential effects of
PHI on cardiac function could contribute to explain its beneficial effect on aer-
obic performance.
We tested the effects of a 1 week treatment with a PHI (DMOG, 150
mg.kg–1, I.P.) or a placebo (NaCl) on both sedentary (Sed) and trained rats
(Ex; trained during 5 weeks before treatment started; 40min at 25 m.min–1 per
day; 5days/week). Our first result was that PHI increased running performance
(+12%, p<0,05) in both Sed and Ex groups. This increased performance was
associated with a major increase in total hemoglobin in PHI-treated animals
(+13% p<0,05). However, regarding cardiac function and cardiac remodeling
no beneficial effect of PHI was observed. Indeed, in hearts of sedentary as
well as exercised rats no significal change in any morphological parameters
(LVEDs, LVEDd, AWTd, PWTd and RWT) was found. Moreover, no change
in systolic function likely to explain enhanced exercise performance was
observed in PHI-treated hearts, when evaluated by intraventricular pressure
probe (Millar®). Finally it is interesting to note that in sedentary rat hearts an
impairment of diastolic function characterized by an altered E/A and dp/dtmin
ratios was found when they were challenged with isoproterenol (0,5 mg.kg-1).
These last results obtained in sedentary hearts could suggest that a more pro-
longed treatment with such PHI could have deleterious consequences on heart
health and point out the danger of such a doping strategy; however, this point
remains to be more precisely investigated. 
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Purpose: Although popularity of ultra-long endurance races is growing, data
on their consequences on cardiac function are still lacking. Thus, we aimed to
assess the progressive cardiac consequences of the World's most challenging
mountain ultra-marathon (Tor des Geants; Italy; 300km; 24000 m D+).
Methods: Resting cardiac evaluations were conducted prior (pre-), during
(mid-; km 150) and after (post-) the race on fifteen participants. Left and right ven-
tricle (LV and RV) morphologies, functions and mechanics were assessed using
standard tissue Doppler imaging and Speckle tracking echocardiography. 
Results: Runners completed the race in 126±15 h. From pre- to post-, the
increase in stroke volume (SV) (103±19 vs. 110±23 vs. 116±21 mL; p<0.001
from pre- to post-race) was concomitant with the increase in LV early filling
(i.e. peak E; 72.9±15.7 vs. 74.6±13.1 vs. 82.1±11.5 cm.s-1; p<0.05). Heart
cavity sizes were 12-19% higher at post-. Significant correlations were found
between percent changes in peak E and LV end-diastolic volume (r=0.56,
p<0.05) or left atrial and right ventricle diastolic areas (r=0.66, p<0.05;
r=0.80, p<0.001; respectively). Resting heart rate and LV systolic strain rates
demonstrated a biphasic adaptation since they were increased at mid- (55±8
vs. 72±11 bpm, p<0.001) but returned to baseline pre- values at post- (55±8
vs. 59±8 bpm, respectively). 
Conclusion: Whereas it is well-described that long duration exercise of several
hours induces a transient LV dysfunction, we observed specific cardiac adapta-
tions characterized by a progressive increase in SV and diastolic function during
much longer exercise; e.g. 4-7 days of mountain running. Our data strongly sup-
port the key role of a cardiac volume overload in these alterations. The underlying
mechanisms of such specific alterations after an extreme mountain ultra-marathon
and their clinical implications remain challenging for the future.
Abstract 0108 – Figure : LV end-diastolic volumes and LA,RA 
and RV end-diastolic areas at pre-, mid- and post-race. Percentage 
changes from baseline are presented for each size or volume cavity
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